CADX Insider Trading Activity and SEC Form 4 Filings
CADX insider trading summary
No open-market insider purchases or sales of Cadence Pharmaceuticals Inc (CADX) have been reported on SEC Form 4 in the past 12 months.
Latest CADX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 17, 2013 | William R Larue | SVP, CFO, Treas, Asst Sec | Sell | $78K (8,500 @ $9.12) |
| Dec 16, 2013 | Hazel M Aker | SVP, GC & Secretary | Sell | $114K (13,014 @ $8.76) |
| Dec 2, 2013 | Scott A. Byrd | SVP, Chief Commercial Officer | Sell | $72K (7,812 @ $9.16) |
| Nov 18, 2013 | William R Larue | SVP, CFO, Treas, Asst Sec | Sell | $68K (9,000 @ $7.60) |
| Nov 15, 2013 | William R Larue | SVP, CFO, Treas, Asst Sec | Sell | $194K (27,000 @ $7.20) |
| Nov 15, 2013 | Hazel M Aker | SVP, GC & Secretary | Sell | $182K (26,028 @ $7.00) |
| Nov 15, 2013 | Scott A. Byrd | SVP, Chief Commercial Officer | Sell | $83K (10,416 @ $8.00) |
| Nov 15, 2013 | Hazel M Aker | SVP, GC & Secretary | Sell | $203K (26,028 @ $7.81) |
| Jul 22, 2013 | Hazel M Aker | SVP, GC & Secretary | Sell | $51K (6,507 @ $7.81) |
| Jul 22, 2013 | Malcolm Lloyd-Smith | SVP, Reg Affairs, Qual & Clin | Sell | $110K (14,000 @ $7.85) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.